Treatment of Diabetic Macrovascular Injury based on Immune Infiltration Characteristics with the Theory of “Pathogenic Turbid Transforms into Heat, Deficiency Fire Scorching Vessels”
|更新时间:2022-04-25
|
Treatment of Diabetic Macrovascular Injury based on Immune Infiltration Characteristics with the Theory of “Pathogenic Turbid Transforms into Heat, Deficiency Fire Scorching Vessels”
Journal of Traditional Chinese MedicineVol. 63, Issue 9, Pages: 825-829(2022)
GUAN Mingdan,WANG Qingfeng,YANG Yufeng,et al.Treatment of Diabetic Macrovascular Injury based on Immune Infiltration Characteristics with the Theory of “Pathogenic Turbid Transforms into Heat, Deficiency Fire Scorching Vessels”[J].Journal of Traditional Chinese Medicine,2022,63(09):825-829.
GUAN Mingdan,WANG Qingfeng,YANG Yufeng,et al.Treatment of Diabetic Macrovascular Injury based on Immune Infiltration Characteristics with the Theory of “Pathogenic Turbid Transforms into Heat, Deficiency Fire Scorching Vessels”[J].Journal of Traditional Chinese Medicine,2022,63(09):825-829.DOI: 10.13288/j.11-2166/r.2022.09.006.
Treatment of Diabetic Macrovascular Injury based on Immune Infiltration Characteristics with the Theory of “Pathogenic Turbid Transforms into Heat, Deficiency Fire Scorching Vessels”
Based on the immune infiltration characteristics found in the modern researches, this paper explored the evolution of the pathogenesis of diabetic macrovascular injury (DMI) by taking pathogenic turbid as the entry point,so as to provide new ideas for the syndrome differentiation and treatment of DMI. It is pointed out that pathogenic turbid induced by spleen and stomach injury is the basic pathogenesis of DMI, and“pathogenic turbid transforming into heat, and deficiency fire scorching vessels” is the core pathogenesis.In clinical practice, the core therapeutic principles and methods are to fortify the spleen and remove turbidity, enrich
yin
and drain fire, and treat the phlegm and stasis simultaneously.
关键词
Keywords
references
VIIGIMAA M , SACHINIDIS A , TOUMPOURLEKA M , et al . Macrovascular complications of type 2 diabetes mellitus [J]. Curr Vasc Pharmacol , 2020 , 18 ( 2 ): 110 - 116 .
SOEHNLEIN O , LIBBY P . Targeting inflammation in atherosclerosis: from experimental insights to the clinic [J]. Nat Rev Drug Discov , 2021 , 20 ( 8 ): 589 - 610 .
MARANTA F , CIANFANELLI L , CIANFLONE D . Glycaemic control and vascular complications in diabetes mellitus type 2 [J]. Adv Exp Med Biol , 2021 , 1307 : 129 - 152 . doi: 10.1007/5584_2020_514 http://dx.doi.org/10.1007/5584_2020_514 .
LUC K , SCHRAMM-LUC A , GUZIK TJ , et al . Oxidative stress and inflammatory markers in prediabetes and diabetes [J]. J Physiol Pharmacol , 2019 , 70 ( 6 ): 809 - 824 .
GENEROSO G , CCPSJANOVSKY , BITTENCOURT MS . Triglycerides and triglyceride-rich lipoproteins in the development and progression of atherosclerosis [J]. Curr Opin Endocrinol Diabetes Obes , 2019 , 26 ( 2 ): 109 - 116 .
BERNELOT MSJ , VERWEIJ SL , SCHNITZLER JG , et al . Remnant cholesterol elicits arterial wall inflammation and a multilevel cellular immune response in humans [J]. Arterioscler Thromb Vasc Biol , 2017 , 37 ( 5 ): 969 - 975 .
WANG N , FULCHER J , ABEYSURIYA N , et al . Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants [J]. Lancet Diabetes Endo , 2020 , 8 ( 1 ): 36 - 49 .
POZNYAK A , GRECHKO AV , POGGIO P , et al . The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation [J]. Int J Mol Sci , 2020 , 21 ( 5 ): 1835 .
THEOFILIS P , SAGRIS M , OIKONOMOU E , et al . Inflammatory mechanisms contributing to endothelial dysfunction [J]. Biomedicines , 2021 , 9 ( 7 ): 781 .
RUSSELL DG , HUANG L , VANDER VBC . Immunometabolism at the interface between macrophages and pathogens [J]. Nat Rev Immunol , 2019 , 19 ( 5 ): 291 - 304 .
KHOURY MK , YANG H , LIU B . Macrophage biology in cardiovascular diseases [J]. Arterioscler Thromb Vasc Biol , 2021 , 41 ( 2 ): e77 - e81 .
MAGUIRE EM , PEARCE SWA , XIAO Q . Foam cell formation: a new target for fighting atherosclerosis and cardiovascular disease [J]. Vasc Pharmacol , 2019 , 112 : 54 - 71 . doi: org/10.1016/j.vph.2018.08.002 http://dx.doi.org/org/10.1016/j.vph.2018.08.002 .
GADDIS DE , PADGETT LE , WU R , et al . Atherosclerosis impairs naive CD4 T-cell responses via disruption of glycolysis [J]. Arterioscler Thromb Vasc Biol , 2021 , 41 ( 9 ): 2387 - 2398 .
SCHÄFER S , ZERNECKE A . CD8+ T cells in atherosclerosis [J]. Cells , 2020 , 10 ( 1 ): 37 . doi: 10.3390/cells10010037 http://dx.doi.org/10.3390/cells10010037 .
ZHAO Y , ZHANG J , ZHANG W , et al . A myriad of roles of dendritic cells in atherosclerosis [J]. Clin Exp Immunol , 2021 , 206 ( 1 ): 12 : 27 .
MA SD , MUSSBACHER M , GALKINA EV . Functional role of B cells in atherosclerosis [J]. Cells , 2021 , 10 ( 2 ): 270 . doi: 10.3390/cells10020270 http://dx.doi.org/10.3390/cells10020270 .
ZHANG N , TSE G , LIU T . Neutrophil-lymphocyte ratio in the immune checkpoint inhibitors-related atherosclerosis [J]. Eur Heart J , 2021 , 42 ( 22 ): 2215 .
VALLEJO J , COCHAIN C , ZERNECKE A , et al . He-terogeneity of immune cells in human atherosclerosis revealed by scRNA-Seq [J]. Cardiovasc Res , 2021 , 117 ( 13 ): 2537 - 2543 .
LI Y , WANG F , IMANI S , et al . Natural killer cells: friend or foe in metabolic diseases [J] Front Immunol , 2021 , 12 : 614429 . doi: org/10.3389/fimmu. 2021. 614429 http://dx.doi.org/org/10.3389/fimmu.2021.614429 .
ZHU Y , XIAN X , WANG Z , et al . Research progress on the relationship between atherosclerosis and inflammation [J]. Biomolecules , 2018 , 8 ( 3 ): 80 .
WANG Y , LUO W , HAN J , et al . MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy [J]. Nat Commun , 2020 , 11 ( 1 ): 2843 - 2863 .
Modern Thinking on the Indications of Daoyin (导引) based on the Theory of "Wei (痿) Diseases should be Treated by Daoyin"
Treatment of Acute Respiratory Distress Syndrome from the Perspective of Qi Deficiency and Blood Stasis
Clinical Research and Basic Study on Effect of Huangqin Qingre Chubi Capsule (黄芩清热除痹胶囊) on Self-Perception of Patients and Immune Inflammation in Rheumatoid Arthritis
Effect of Modified Zhigancao Granules (炙甘草汤加味颗粒) on Early Recurrence Following Radiofrequency Ablation in Patients with Atrial Fibrillation of Qi-Yin Deficiency Syndrome:A Randomized,Double-Blind,Placebo-Controlled Trial
Effect of Ziyu Ointment (紫榆膏) on Postoperative Incisional Pain and Inflammatory Response by Regulating SDF-1/CXCR4 Pathway
Related Author
YU Yan
CHEN Xueyin
YANG Lihong
LIU Shaonan
CHEN Yu
LIU Lixiang
YUE Ping
WU Jinpeng
Related Institution
Second Clinical Medical College, Guangzhou University of Chinese Medicine
Guangdong Provincial Hospital of Chinese Medicine
Institute of Biomedical Engineering, Chinese Academy of Medical Sciences
Tianjin University of Traditional Chinese Medicine
Institute of Basic Theory for Chinese Medicine,China Academy of Chinese Medical Sciences